Takanori Suzuki

发表

Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection

K. Matsuura, Etsuko Iio, Yasuhito Tanaka, 2021, PloS one.

Primary Sclerosing Cholangitis and Autoimmune Hepatitis Overlapping Syndrome Complicated by Ulcerative Colitis

K. Matsuura, H. Kataoka, I. Naitoh, 2022, Internal medicine.

Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core‐related antigen assay

K. Matsuura, S. Iida, S. Yagi, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation.

K. Matsuura, S. Yagi, Etsuko Iio, 2021, Journal of hepatology.

Serum angiopoietin‐2 levels predict regression of Mac‐2 binding protein glycosylation isomer‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents

K. Matsuura, H. Kataoka, S. Nojiri, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation

K. Matsuura, H. Kataoka, S. Kusumoto, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation

A. Tamori, K. Matsuura, S. Yagi, 2022, Journal of Gastroenterology.

The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis

K. Matsuura, H. Kataoka, S. Nojiri, 2023, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of minocycline hydrochloride aspiration sclerotherapy with additional monoethanolamine oleate aspiration sclerotherapy for symptomatic hepatic cysts

K. Matsuura, H. Kataoka, Yoshinori Mori, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease.

M. Kurosaki, K. Matsuura, M. Sugiyama, 2023, Journal of gastroenterology.

Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents

K. Matsuura, Etsuko Iio, Katsuya Nagaoka, 2024, Oncology.

MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents.

K. Matsuura, Etsuko Iio, Katsuya Nagaoka, 2024, Journal of gastroenterology.

Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus– and Hepatitis C Virus–Related Hepatocellular Carcinoma

H. Toyoda, E. Ogawa, Y. Dan, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis

K. Matsuura, S. Nojiri, Yuta Suzuki, 2023, Cancer medicine.

Prognostic nutritional index after introduction of atezolizumab with bevacizumab predicts prognosis in advanced hepatocellular carcinoma: A multicenter study.

K. Matsuura, S. Nojiri, Yuta Suzuki, 2024, Oncology.

Factors associated with low hepatitis B surface antigen levels in chronic hepatitis B patients treated with nucleot(s)ide analogs.

K. Matsuura, Hayato Kawamura, Takanori Suzuki, 2024, Hepatology research : the official journal of the Japan Society of Hepatology.